admin Site Admin
Joined: 06 Jan 2008 Posts: 45
|
Posted: Thu Jan 24, 2008 1:14 am Post subject: Giaconda Signs Agreement to Take Myoconda® to Market in Euro |
|
|
GIACONDA Sydney, Australia 19 September 2007. Giaconda Ltd (ASX: GIA) today announced that it has entered a cooperative development agreement with Prague Clinical Services, s.r.o. of the Czech Republic to further the development of its lead product, Myoconda®, for the treatment of MAP infection in Crohn’s Disease. Under the terms of the agreement Giaconda and Prague Clinical Services will collaborate to complete a Phase III clinical study across Europe as well as regulatory development on Myoconda to enable registration with the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK.
|
|